Breaking Eroom’s Law
Ringel, Michael S., Scannell, Jack W., Baedeker, Mathias, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.12.2020)
Published in Nature reviews. Drug discovery (01.12.2020)
Get full text
Journal Article
2020 FDA approvals: momentum kept despite COVID-19, but value falls
Baedeker, Mathias, Ringel, Michael, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2021)
Published in Nature reviews. Drug discovery (01.02.2021)
Get full text
Journal Article
Value of 2019 FDA approvals: back to the recent average
Baedeker, Mathias, Ringel, Michael, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2020)
Published in Nature reviews. Drug discovery (01.02.2020)
Get full text
Journal Article
2018 FDA approvals hit all time high — but average value slips again
Baedeker, Mathias, Ringel, Michael, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2019)
Published in Nature reviews. Drug discovery (01.02.2019)
Get full text
Journal Article
2021 FDA approvals: value driven by COVID-19 vaccines
Baedeker, Mathias, Ringel, Michael S., Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2022)
Published in Nature reviews. Drug discovery (01.02.2022)
Get full text
Journal Article
2023 FDA approvals: unprecedented volume at moderate value
Baedeker, Mathias, Ringel, Michael S., Möller, Clemens C.
Published in Nature reviews. Drug discovery (01.02.2024)
Published in Nature reviews. Drug discovery (01.02.2024)
Get full text
Journal Article
2022 FDA approval number dips: a COVID-19 hangover?
Baedeker, Mathias, Ringel, Michael S., Möller, Clemens C., Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2023)
Published in Nature reviews. Drug discovery (01.02.2023)
Get full text
Journal Article
Market watch: 2017 FDA drug approvals: number rebounds but average value slips
Baedeker, Mathias, Ringel, Michael, Panier, Valery, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2018)
Published in Nature reviews. Drug discovery (01.02.2018)
Get full text
Journal Article
R&D productivity: on the comeback trail
Schulze, Ulrik, Baedeker, Mathias, Chen, Yen Ting, Greber, David
Published in Nature reviews. Drug discovery (01.05.2014)
Published in Nature reviews. Drug discovery (01.05.2014)
Get full text
Journal Article
2017 FDA drug approvals: number rebounds but average value slips
Baedeker, Mathias, Ringel, Michael, Panier, Valery, Schulze, Ulrik
Published in Nature reviews. Drug discovery (01.02.2018)
Published in Nature reviews. Drug discovery (01.02.2018)
Get full text
Journal Article
Value of 2016 FDA drug approvals: reversion to the mean?
Schulze, Ulrik, Ringel, Michael, Panier, Valery, Baedeker, Mathias
Published in Nature reviews. Drug discovery (02.02.2017)
Published in Nature reviews. Drug discovery (02.02.2017)
Get full text
Journal Article
Market watch: Value of 2016 FDA drug approvals: reversion to the mean?
Schulze, Ulrik, Ringel, Michael, Panier, Valery, Baedeker, Mathias
Published in Nature reviews. Drug discovery (01.02.2017)
Published in Nature reviews. Drug discovery (01.02.2017)
Get full text
Journal Article